Literature DB >> 1155539

Effects of drug vehicles on ocular uptake of tetracycline.

R E Hardberger, C Hanna, R Goodart.   

Abstract

Varying concentrations of tetracycline hydrochloride were topically applied to the rabbit eye in several ophthalmic vehicles. The antibiotic levels in the corneal epithelium, aqueous humor, and lens were markedly elevated by increasing the drug concentration and the drug contact time with the eye. The ocular levels of tetracycline were increased by the vehicle in this ascending order: isotonic saline, 1.4% polyvinyl alcohol, 1% alpha-methylcellulose, and a 6:4 mixture of white petrolatum-mineral oil ointment. Tetracycline hydrochloride as a 2.0% suspension in ointment produced anterior chamber and corneal concentrations for several hours in the range of bacteriostasis for many gram-negative bacteria that occasionally invade the eye.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155539     DOI: 10.1016/0002-9394(75)90883-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Time course of changes in ocular wavefront aberration after administration of eye ointment.

Authors:  T Hiraoka; T Yamamoto; F Okamoto; T Oshika
Journal:  Eye (Lond)       Date:  2012-07-20       Impact factor: 3.775

Review 2.  Nanostructured materials for ocular delivery: nanodesign for enhanced bioadhesion, transepithelial permeability and sustained delivery.

Authors:  Jean Kim; Erica B Schlesinger; Tejal A Desai
Journal:  Ther Deliv       Date:  2015

3.  Ocular pharmacokinetic models of clonidine-3H hydrochloride.

Authors:  C H Chiang; R D Schoenwald
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

Review 4.  Treatment of bacterial ulcers of the cornea in the rabbit: a comparison of administration by eye drops and subconjunctival injections.

Authors:  J Baum
Journal:  Trans Am Ophthalmol Soc       Date:  1982

5.  Assessment of the precorneal residence of an ophthalmic ointment in healthy subjects.

Authors:  J L Greaves; C G Wilson; A T Birmingham
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.